[go: up one dir, main page]

NO863321D0 - Fysikalsk modifisert beclomethasondipropionat egnet for anvendelse i aerosoler. - Google Patents

Fysikalsk modifisert beclomethasondipropionat egnet for anvendelse i aerosoler.

Info

Publication number
NO863321D0
NO863321D0 NO1986863321A NO863321A NO863321D0 NO 863321 D0 NO863321 D0 NO 863321D0 NO 1986863321 A NO1986863321 A NO 1986863321A NO 863321 A NO863321 A NO 863321A NO 863321 D0 NO863321 D0 NO 863321D0
Authority
NO
Norway
Prior art keywords
beclomethasondipropionate
aerosols
physically modified
physically
modified
Prior art date
Application number
NO1986863321A
Other languages
English (en)
Other versions
NO170516B (no
NO863321L (no
NO170516C (no
Inventor
Philip Anthony Jinks
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of NO863321D0 publication Critical patent/NO863321D0/no
Publication of NO863321L publication Critical patent/NO863321L/no
Publication of NO170516B publication Critical patent/NO170516B/no
Publication of NO170516C publication Critical patent/NO170516C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO863321A 1984-12-19 1986-08-18 Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat NO170516C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848432063A GB8432063D0 (en) 1984-12-19 1984-12-19 Physically modified steroids
PCT/GB1985/000588 WO1986003750A1 (en) 1984-12-19 1985-12-16 Physically modified beclomethasone dipropionate suitable for use in aerosols

Publications (4)

Publication Number Publication Date
NO863321D0 true NO863321D0 (no) 1986-08-18
NO863321L NO863321L (no) 1986-08-18
NO170516B NO170516B (no) 1992-07-20
NO170516C NO170516C (no) 1992-10-28

Family

ID=10571434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863321A NO170516C (no) 1984-12-19 1986-08-18 Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat

Country Status (14)

Country Link
US (1) US4810488A (no)
EP (1) EP0205530B1 (no)
JP (1) JPH0714880B2 (no)
KR (1) KR910004338B1 (no)
AU (1) AU587010B2 (no)
CA (1) CA1253806A (no)
DE (1) DE3568334D1 (no)
ES (1) ES8702136A1 (no)
GB (1) GB8432063D0 (no)
IE (1) IE58686B1 (no)
NO (1) NO170516C (no)
NZ (1) NZ214544A (no)
WO (1) WO1986003750A1 (no)
ZA (1) ZA859631B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
DE69124374T2 (de) * 1990-06-29 1997-06-19 Fisons Plc, Ipswich, Suffolk Druckaerosolzusammensetzung
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
AU658854B2 (en) * 1990-10-18 1995-05-04 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
EP0616524B1 (en) * 1991-12-12 1998-10-07 Glaxo Group Limited Medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
TW244350B (no) * 1991-12-14 1995-04-01 Hoechst Ag
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ATE204743T1 (de) 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
MX9304585A (es) 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
JP4484247B2 (ja) 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
HUP9901575A3 (en) * 1996-04-29 1999-11-29 Dura Pharmaceuticals Inc San D Methods of dry powder inhalation
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
JP4700160B2 (ja) 2000-03-13 2011-06-15 株式会社半導体エネルギー研究所 半導体装置
JP4683688B2 (ja) 2000-03-16 2011-05-18 株式会社半導体エネルギー研究所 液晶表示装置の作製方法
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
CA2538237A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
EP2120875B1 (en) * 2007-02-11 2018-07-11 Map Pharmaceuticals Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR20120015334A (ko) 2009-05-29 2012-02-21 펄 테라퓨틱스 인코포레이티드 활성제의 호흡기 전달용 조성물, 및 연관된 방법 및 시스템
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
JP6158588B2 (ja) 2012-05-31 2017-07-05 株式会社半導体エネルギー研究所 発光装置
EP2968152B2 (en) 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
CH643567A5 (de) 1979-05-21 1984-06-15 Syntex Corp Verfahren zur herstellung einer kristallinen form von flunisolid.
IT1121513B (it) * 1979-05-28 1986-04-02 Chiesi Farma Spa Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol
ATE3774T1 (de) * 1980-05-02 1983-06-15 Schering Corporation Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
DK336485A (da) * 1984-07-25 1986-01-26 Hovione Int Ltd Fremgangsmaade til fremstilling af et diisopropylaetersolvat af beclomethason-17,21-dipropionat

Also Published As

Publication number Publication date
KR910004338B1 (ko) 1991-06-26
IE853231L (en) 1986-06-19
ES8702136A1 (es) 1986-12-16
NO170516B (no) 1992-07-20
AU5308786A (en) 1986-07-22
NO863321L (no) 1986-08-18
KR870700070A (ko) 1987-02-28
EP0205530B1 (en) 1989-02-22
CA1253806A (en) 1989-05-09
JPS62501706A (ja) 1987-07-09
JPH0714880B2 (ja) 1995-02-22
ES550076A0 (es) 1986-12-16
DE3568334D1 (en) 1989-03-30
ZA859631B (en) 1987-05-27
IE58686B1 (en) 1993-11-03
US4810488A (en) 1989-03-07
AU587010B2 (en) 1989-08-03
EP0205530A1 (en) 1986-12-30
NZ214544A (en) 1989-04-26
NO170516C (no) 1992-10-28
WO1986003750A1 (en) 1986-07-03
GB8432063D0 (en) 1985-01-30

Similar Documents

Publication Publication Date Title
NO863321L (no) Fysikalsk modifisert beclomethasondipropionat egnet for anvendelse i aerosoler.
DE3382547D1 (de) Sekretorische expression in eukaryoten.
FI853313A0 (fi) Speciallins foer glasoegon.
FI864620A0 (fi) Substituerade bensyletrar.
ES539731A0 (es) Perfeccionamientos en calandrias
FI864634A0 (fi) Flytande diskmedel foer diskning foer hand i kallt vatten.
FI852573L (fi) Foerbaettringar i anslutning till hjaelpmedel foer handikappade.
FI893497A0 (fi) Elektrokemisk cell med dubbelverkande elektrod.
FI820427L (fi) Foerbindning foer in i varandra gripande metall- eller plastprofiler
FI860611A7 (fi) Anordning i skaerbraennare.
FI851586A7 (fi) 3-substituoidut tiopyronit.
DK391786A (da) Fysisk modificeret beclomethasondipropionat egnet til anvendelse i aerosoler
KR860004850U (ko) 성냥개비 정렬 공급장치
FI851796A0 (fi) Kamflaenskonstruktion foer fastsaettning av tvao in i varandra placerbara roerformiga stycken.
NL186107C (nl) Kleding-reinigingsbedrijf.
FI854369A0 (fi) Styranordning foer plasmagenerator.
FI843699A7 (fi) Framstaellningstrumma foer asfaltmassa.
FI875494A0 (fi) Anordning foer lastbehandling i hamnar.
IT8404258V0 (it) Contenitore in particolare per minuterie in genere.
IT8420644V0 (it) Carburatore in particolare per modellismo.
ES282075Y (es) Envase perfeccionado.
ES283707Y (es) Envase perfeccionado.
ES282077Y (es) Recipiente perfeccionado.
FI841757A0 (fi) Arrangemang foer montering av en inombordsmotor in i en baot.
AR230786A1 (es) Mejoras en barriletes

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2003